AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Virtual Booth

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: N'-methylamisulpride, N'-methyl amisulpride, N81wkw91xf, Unii-n81wkw91xf, 2227154-23-4, 4-(methylamino)-n-(((2rs)-1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide.

Molecular Formula

C₁₈H₂₉N₃O₄S

Molecular Weight

383.5 g/mol

InChI Key

NXKXZXNNWRYXRE-UHFFFAOYSA-N

FDA UNII

N81WKW91XF

LB-102 is a small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication.

1 2D Structure

Lb-102

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-4-(methylamino)benzamide

2.1.2 InChI

InChI=1S/C18H29N3O4S/c1-5-21-9-7-8-13(21)12-20-18(22)14-10-17(26(23,24)6-2)15(19-3)11-16(14)25-4/h10-11,13,19H,5-9,12H2,1-4H3,(H,20,22)

2.1.3 InChI Key

NXKXZXNNWRYXRE-UHFFFAOYSA-N

2.2 Other Identifiers

2.2.1 UNII

N81WKW91XF

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. N'-methylamisulpride

2. N'-methyl Amisulpride

3. N81wkw91xf

4. Unii-n81wkw91xf

5. 2227154-23-4

6. 4-(methylamino)-n-(((2rs)-1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide.

7. Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-4-(methylamino)-

8. Refchem:152592

9. Rac-n-methyl Amisulpride

10. Orb2695637

11. Chembl4594422

12. Schembl20189909

13. Schembl29494158

14. Bdbm313180

15. Ex-a11598

16. Lb 102

17. Us10167256, Compound 102

18. 4-methylamino-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl))-2-methoxybenzamide

19. N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxy-4-(methylamino)benzamide;

2.4 Create Date

2018-06-23

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₉N₃O₄S
Molecular Weight	383.5 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	8
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	96.1
Heavy Atom Count	26
Formal Charge	0
Complexity	563
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Lb-102 manufacturers, exporters & distributors on PharmaCompass

LB 102

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

MARKET PLACE

DIGITAL CONTENT

What are you looking for?